Bone marrow microenvironment: A newly recognized target for diabetes-induced cellular damage

Endocrine, Metabolic and Immune Disorders - Drug Targets

Volumn 12, Issue 2, 2012, Pages 159-167

  Mangialardi, Giuseppe ^a   Oikawa, Atsuhiko ^a   Reni, Carlotta ^a   Madeddu, Paolo ^a  

^a BRISTOL ROYAL INFIRMARY   (United Kingdom)

Author keywords

Bone marrow; Diabetes; Ischemia; Microenvironment; Osteoblastic niche; Stem cells; Vascular niche

Indexed keywords

ANGIOPOIETIN 1; C REACTIVE PROTEIN; CATHEPSIN G; CATHEPSIN K; CD34 ANTIGEN; ELASTASE; GELATINASE A; GELATINASE B; NERVE CELL ADHESION MOLECULE; NOTCH RECEPTOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPONTIN; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1ALPHA; THROMBOPOIETIN; WNT PROTEIN;

BONE MARROW; CARDIOVASCULAR RISK; CELL ACTIVATION; CELL DAMAGE; CELL DIFFERENTIATION; CELL INTERACTION; DIABETES MELLITUS; DIABETIC NEUROPATHY; ENDOTHELIAL PROGENITOR CELL; HEMATOPOIETIC STEM CELL; HUMAN; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OXIDATIVE STRESS; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BONE MARROW; CELLULAR MICROENVIRONMENT; DIABETIC ANGIOPATHIES; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; OSTEOCLASTS; OXIDATIVE STRESS; RATS; SEVERITY OF ILLNESS INDEX; WOUND HEALING;

EID: 84861166750     PISSN: 18715303     EISSN: 22123873     Source Type: Journal    
DOI: 10.2174/187153012800493530     Document Type: Review

References (92)

1. Heidenreich, P. A.; Trogdon, J. G.; Khavjou, O. A.; Butler, J.; Dracup, K.; Ezekowitz, M. D.; Finkelstein, E. A.; Hong, Y.; Johnston, S. C.; Khera, A.; Lloyd-Jones, D. M.; Nelson, S. A.; Nichol, G.; Orenstein, D.; Wilson, P. W. and Woo, Y. J. (2011) Forecasting the future of cardiovascular disease in the United States: a policy statement from the American Heart Association. Circulation, 123, 933-944.
2. Asahara, T.; Murohara, T.; Sullivan, A.; Silver, M.; van der Zee, R.; Li, T.; Witzenbichler, B.; Schatteman, G. and Isner, J. M. (1997) Isolation of putative progenitor endothelial cells for angiogenesis. Science, 275, 964-967.
3. Fadini, G. P.; Maruyama, S.; Ozaki, T.; Taguchi, A.; Meigs, J.; Dimmeler, S.; Zeiher, A. M.; de Kreutzenberg, S. and Avogaro, A.; Nickenig, G.; Schmidt-Lucke, C.; Werner, N. (2010) Circulating progenitor cell count for cardiovascular risk stratification: a pooled analysis. PLoS One, 5, e11488.
4. Oikawa, A.; Siragusa, M.; Quaini, F.; Mangialardi, G.; Katare, R. G.; Caporali, A.; van Buul, J. D.; van Alphen, F. P.; Graiani, G.; Spinetti, G.; Kraenkel, N.; Prezioso, L.; Emanueli, C. and Madeddu, P. (2010) Diabetes mellitus induces bone marrow microangiopathy. Arterioscler. Thromb. Vasc. Biol., 30, 498-508.
5. Orlandi, A.; Chavakis, E.; Seeger, F.; Tjwa, M.; Zeiher, A. M. and Dimmeler, S. (2010) Long-term diabetes impairs repopulation of hematopoietic progenitor cells and dysregulates the cytokine expression in the bone marrow microenvironment in mice. Basic Res. Cardiol., 105, 703-712.
6. Till, J. E. and McCulloch, E. A. (2011) A direct measurement of the radiation sensitivity of normal mouse bone marrow cells. 1961. Radiat. Res., 175, 145-149.
7. Weissman, I. L. (2000) Stem cells: units of development, units of regeneration, and units in evolution. Cell, 100, 1, 157-168.
8. Kondo, M.; Wagers, A. J.; Manz, M. G.; Prohaska, S. S.; Scherer, D. C.; Beilhack, G. F.; Shizuru, J. A. and Weissman, I. L. (2003) Biology of hematopoietic stem cells and progenitors: implications for clinical application. Annu. Rev. Immunol., 21, 759-806.
9. Osawa, M.; Hanada, K.; Hamada, H. and Nakauchi, H. (1996) Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell. Science, 273, 242-245.
10. Wagers, A. J.; Sherwood, R. I.; Christensen, J. L. and Weissman, I. L. (2002) Little evidence for developmental plasticity of adult hematopoietic stem cells. Science, 297, 2256-2259.
11. Matsuzaki, Y.; Kinjo, K.; Mulligan, R. C. and Okano, H. (2004) Unexpectedly efficient homing capacity of purified murine hematopoietic stem cells. Immunity, 20, 87-93.
12. Kiel, M. J.; Yilmaz, O. H.; Iwashita, T.; Terhorst, C. and Morrison, S. J. (2005) SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells. Cell, 121, 1109-1121.
13. Morita, Y.; Ema, H. and Nakauchi, H. (2010) Heterogeneity and hierarchy within the most primitive hematopoietic stem cell compartment. J. Exp. Med., 207, 1173-1182.
14. Bailey, A. S.; Jiang, S.; Afentoulis, M.; Baumann, C. I.; Schroeder, D. A.; Olson, S. B.; Wong, M. H. and Fleming, W. H. (2004) Transplanted adult hematopoietic stems cells differentiate into functional endothelial cells. Blood, 103, 13-19.
15. Grant, M. B.; May, W. S.; Caballero, S.; Brown, G. A.; Guthrie, S. M.; Mames, R. N.; Byrne, B. J.; Vaught, T.; Spoerri, P. E.; Peck, A. B. and Scott, E. W. (2002) Adult hematopoietic stem cells provide functional hemangioblast activity during retinal neovascularization. Nat. Med., 8, 607-612.
16. Krankel, N.; Katare, R. G.; Siragusa, M.; Barcelos, L. S.; Campagnolo, P.; Mangialardi, G.; Fortunato, O.; Spinetti, G.; Tran, N.; Zacharowski, K.; Wojakowski, W.; Mroz, I.; Herman, A.; Manning Fox, J. E.; MacDonald, P. E.; Schanstra, J. P.; Bascands, J. L.; Ascione, R.; Angelini, G.; Emanueli, C. and Madeddu, P. (2008) Role of kinin B2 receptor signaling in the recruitment of circulating progenitor cells with neovascularization potential. Cir. Res., 103, 1335-1343.
17. Walter, D. H.; Haendeler, J.; Reinhold, J.; Rochwalsky, U.; Seeger, F.; Honold, J.; Hoffmann, J.; Urbich, C.; Lehmann, R.; Arenzana-Seisdesdos, F.; Aicher, A.; Heeschen, C.; Fichtlscherer, S.; Zeiher, A. M. and Dimmeler, S. (2005) Impaired CXCR4 signaling contributes to the reduced neovascularization capacity of endothelial progenitor cells from patients with coronary artery disease. Cir. Res., 97, 1142-1151.
18. Kim, H.; Cho, H. J.; Kim, S. W.; Liu, B.; Choi, Y. J.; Lee, J.; Sohn, Y. D.; Lee, M. Y.; Houge, M. A. and Yoon, Y. S. (2010) CD31+ cells represent highly angiogenic and vasculogenic cells in bone marrow: novel role of nonendothelial CD31+ cells in neovascularization and their therapeutic effects on ischemic vascular disease. Circ. Res., 107, 602-614.
19. Balsam, L. B.; Wagers, A. J.; Christensen, J. L.; Kofidis, T.; Weissman, I. L. and Robbins, R. C. (2004) Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature, 428, 668-673.
20. Murry, C. E.; Soonpaa, M. H.; Reinecke, H.; Nakajima, H.; Nakajima, H. O.; Rubart, M.; Pasumarthi, K. B.; Virag, J. I.; Bartelmez, S. H.; Poppa, V.; Bradford, G.; Dowell, J. D.; Williams, D. A. and Field, L. J. (2004) Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature, 428, 664-668.
21. Kawamoto, A. and Losordo, D. W. (2008) Endothelial progenitor cells for cardiovascular regeneration. Trends Cardiovasc. Med., 18, 33-37.
22. Yang, J.; Ii, M.; Kamei, N.; Alev, C.; Kwon, S. M.; Kawamoto, A.; Akimaru, H.; Masuda, H.; Sawa, Y. and Asahara, T. (2011) CD34 cells represent highly functional endothelial progenitor cells in murine bone marrow. PLoS One, 6, e20219.
23. Fadini, G. P.; Boscaro, E.; de Kreutzenberg, S.; Agostini, C.; Seeger, F.; Dimmeler, S.; Zeiher, A.; Tiengo, A. and Avogaro, A. (2010) Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes. Diabetes care, 33, 5, 1097-1102.
24. Krankel, N.; Armstrong, S. P.; McArdle, C. A.; Dayan, C.; Madeddu, P. Distinct kinin-induced functions are altered in circulating cells of young type 1 diabetic patients. PloS one, 5, e11146.
25. Lo Celso, C.; Fleming, H. E.; Wu, J. W.; Zhao, C. X.; Miake-Lye, S.; Fujisaki, J.; Cote, D.; Rowe, D. W.; Lin, C. P. and Scadden, D. T. (2009) Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche. Nature, 457, 92-96.
26. Kiel, M. J. and Morrison, S. J. (2008) Uncertainty in the niches that maintain haematopoietic stem cells. Nat. Rev. Immunol., 8, 290-301.
27. Raaijmakers, M. H. and Scadden, D. T. (2008) Evolving concepts on the microenvironmental niche for hematopoietic stem cells. Curr. Opin. Hematol., 15, 301-306.
28. Calvi, L. M.; Adams, G. B.; Weibrecht, K. W.; Weber, J. M.; Olson, D. P.; Knight, M. C.; Martin, R. P.; Schipani, E.; Divieti, P.; Bringhurst, F. R.; Milner, L. A.; Kronenberg, H. M. and Scadden, D. T. (2003) Osteoblastic cells regulate the haematopoietic stem cell niche. Nature, 425, 841-846.
29. Weber, J. M. and Calvi, L. M. (2010) Notch signaling and the bone marrow hematopoietic stem cell niche. Bone, 46, 281-285.
30. Zhang, J.; Niu, C.; Ye, L.; Huang, H.; He, X.; Tong, W. G.; Ross, J.; Haug, J.; Johnson, T.; Feng, J. Q.; Harris, S.; Wiedemann, L. M.; Mishina, Y. and Li, L. (2003) Identification of the haematopoietic stem cell niche and control of the niche size. Nature, 425, 836-841.
31. Ikuta, K. and Weissman, I. L. (1992) Evidence that hematopoietic stem cells express mouse c-kit but do not depend on steel factor for their generation. Proc. Nat. Acad. Sci. USA, 89, 4, 1502-1506.
32. Miller, C. L.; Rebel, V. I.; Helgason, C. D.; Lansdorp, P. M. and Eaves, C. J. (1997) Impaired steel factor responsiveness differentially affects the detection and long-term maintenance of fetal liver hematopoietic stem cells in vivo. Blood, 89, 1214-1223.
33. Audet, J.; Miller, C. L.; Eaves, C. J. and Piret, J. M. (2002) Common and distinct features of cytokine effects on hematopoietic stem and progenitor cells revealed by dose-response surface analysis. Biotech. Bioeng., 80, 393-404.
34. Zandstra, P. W.; Conneally, E.; Petzer, A. L.; Piret, J. M. and Eaves, C. J. (1997) Cytokine manipulation of primitive human hematopoietic cell self-renewal. Proc. Nat. Acad. Sci. USA, 94, 4698-4703.
35. Arai, F.; Hirao, A.; Ohmura, M.; Sato, H.; Matsuoka, S.; Takubo, K.; Ito, K.; Koh, G. Y. and Suda, T. (2004) Tie2/angiopoietin-1 signaling regulates hematopoietic stem cell quiescence in the bone marrow niche. Cell, 118, 149-161.
36. Kim, I.; Kim, H. G.; So, J. N.; Kim, J. H.; Kwak, H. J. and Koh, G. Y. (2000) Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway. Circ. Res., 86, 24-29.
37. Arai, F.; Yoshihara, H.; Hosokawa, K.; Nakamura, Y.; Gomei, Y.; Iwasaki, H. and Suda, T. (2009) Niche regulation of hematopoietic stem cells in the endosteum. Ann. N.Y. Acad. Sci., 1176, 36-46.
38. Nilsson, S. K.; Johnston, H. M.; Whitty, G. A.; Williams, B.; Webb, R. J.; Denhardt, D. T.; Bertoncello, I.; Bendall, L. J.; Simmons, P. J. and Haylock, D. N. (2005) Osteopontin, a key component of the hematopoietic stem cell niche and regulator of primitive hematopoietic progenitor cells. Blood, 106, 1232-1239.
39. Reya, T.; Duncan, A. W.; Ailles, L.; Domen, J.; Scherer, D. C.; Willert, K.; Hintz, L.; Nusse, R. and Weissman, I. L. (2003) A role for Wnt signalling in self-renewal of haematopoietic stem cells. Nature, 423, 409-414.
40. Kiel, M. J.; Radice, G. L. and Morrison, S. J. (2007) Lack of evidence that hematopoietic stem cells depend on N-cadherinmediated adhesion to osteoblasts for their maintenance. Cell Stem Cell, 1, 204-217.
41. Butler, J. M.; Nolan, D. J.; Vertes, E. L.; Varnum-Finney, B.; Kobayashi, H.; Hooper, A. T.; Seandel, M.; Shido, K.; White, I. A.; Kobayashi, M.; Witte, L.; May, C.; Shawber, C.; Kimura, Y.; Kitajewski, J.; Rosenwaks, Z.; Bernstein, I. D. and Rafii, S. (2010) Endothelial cells are essential for the self-renewal and repopulation of Notch-dependent hematopoietic stem cells. Cell Stem Cell, 6, 3, 251-264.
42. Hooper, A. T.; Butler, J. M.; Nolan, D. J.; Kranz, A.; Iida, K.; Kobayashi, M.; Kopp, H. G.; Shido, K.; Petit, I.; Yanger, K.; James, D.; Witte, L.; Zhu, Z.; Wu, Y.; Pytowski, B.; Rosenwaks, Z.; Mittal, V.; Sato, T. N. and Rafii, S. (2009) Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells. Cell Stem Cell, 4, 263-274.
43. Scadden, D. T. (2008) Circadian rhythms: stem cells traffic in time. Nature, 452, 416-417.
44. Nance, D. M. and Sanders, V. M. (2007) Autonomic innervation and regulation of the immune system (1987-2007). Brain Behavior Immunity, 21, 736-745.
45. Kollet, O.; Dar, A.; Shivtiel, S.; Kalinkovich, A.; Lapid, K.; Sztainberg, Y.; Tesio, M.; Samstein, R. M.; Goichberg, P.; Spiegel, A.; Elson, A. and Lapidot, T. (2006) Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nat. Med., 12, 657-664.
46. Nakagawa, N.; Kinosaki, M.; Yamaguchi, K.; Shima, N.; Yasuda, H.; Yano, K.; Morinaga, T. and Higashio, K. (1998) RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem. Biophys. Res. Comm., 253, 2, 395-400.
47. Wong, B. R.; Rho, J.; Arron, J.; Robinson, E.; Orlinick, J.; Chao, M.; Kalachikov, S.; Cayani, E.; Bartlett, F. S., 3rd; Frankel, W. N.; Lee, S. Y. and Choi, Y. (1997) TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J. Biol. Chem., 272, 25190-25194.
48. Kim, H. H.; Lee, D. E.; Shin, J. N.; Lee, Y. S.; Jeon, Y. M.; Chung, C. H.; Ni, J.; Kwon, B. S. and Lee, Z. H. (1999) Receptor activator of NF-kappaB recruits multiple TRAF family adaptors and activates c-Jun N-terminal kinase. FEBS Lett., 443, 297-302.
49. Boyle, W. J.; Simonet, W. S. and Lacey, D. L. (2003) Osteoclast differentiation and activation. Nature, 423, 337-342.
50. Kollet, O.; Dar, A. and Lapidot, T. (2007) The multiple roles of osteoclasts in host defense: bone remodeling and hematopoietic stem cell mobilization. Ann. Rev. Immunol., 25, 51-69.
51. Jin, T. (2008) The WNT signalling pathway and diabetes mellitus. Diabetologia, 51, 1771-1780.
52. Welters, H. J. and Kulkarni, R. N. (2008) Wnt signaling: relevance to beta-cell biology and diabetes. Trends Endocrinol. Metab., 19, 349-355.
53. Kubota, T.; Michigami, T. and Ozono, K. (2009) Wnt signaling in bone metabolism. J. Bone Miner. Metab., 27, 265-271.
54. Aicher, A.; Kollet, O.; Heeschen, C.; Liebner, S.; Urbich, C.; Ihling, C.; Orlandi, A.; Lapidot, T.; Zeiher, A. M. and Dimmeler, S. (2008) The Wnt antagonist Dickkopf-1 mobilizes vasculogenic progenitor cells via activation of the bone marrow endosteal stem cell niche. Circ. Res., 103, 796-803.
55. Parmar, K.; Mauch, P.; Vergilio, J. A.; Sackstein, R. and Down, J. D. (2007) Distribution of hematopoietic stem cells in the bone marrow according to regional hypoxia. Proc. Natl. Acad. Sci. USA, 104, 5431-5436.
56. Durand, R. E.; Chaplin, D. J. and Olive, P. L. (1990) Cell sorting with Hoechst or carbocyanine dyes as perfusion probes in spheroids and tumors. Methods Cell Biol., 33, 509-518.
57. Brownlee, M. (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes, 54, 1615-1625.
58. Frank, R. N. (2004) Diabetic retinopathy. N. Engl. J. Med., 350, 48-58.
59. Harhaj, N. S.; Felinski, E. A.; Wolpert, E. B.; Sundstrom, J. M.; Gardner, T. W. and Antonetti, D. A. (2006) VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest. Ophthalmol. Vis. Sci., 47, 5106-5115.
60. Rangasamy, S.; Srinivasan, R.; Maestas, J.; McGuire, P. G. and Das, A. (2011) A potential role for angiopoietin 2 in the regulation of the blood-retinal barrier in diabetic retinopathy. Invest. Ophthalmol. Vis. Sci., 52, 3784-3791.
61. Joussen, A. M.; Poulaki, V.; Qin, W.; Kirchhof, B.; Mitsiades, N.; Wiegand, S. J.; Rudge, J.; Yancopoulos, G. D. and Adamis, A. P. (2002) Retinal vascular endothelial growth factor induces intercellular adhesion molecule-1 and endothelial nitric oxide synthase expression and initiates early diabetic retinal leukocyte adhesion in vivo. Am. J. Pathol., 160, 501-509.
62. Lapidot, T.; Dar, A. and Kollet, O. (2005) How do stem cells find their way home? Blood, 106, 1901-1910.
63. Bouillon, R. (1991) Diabetic bone disease. Calcif. Tissue Int., 49, 155-160.
64. Schwartz, A. V. (2003) Diabetes mellitus: Does it affect bone? Calcif. Tissue Int., 73, 515-519.
65. Kemink, S. A.; Hermus, A. R.; Swinkels, L. M.; Lutterman, J. A. and Smals, A. G. (2000) Osteopenia in insulin-dependent diabetes mellitus; prevalence and aspects of pathophysiology. J. Endocrinol. Invest., 23, 295-303.
66. Forst, T.; Pfutzner, A.; Kann, P.; Schehler, B.; Lobmann, R.; Schafer, H.; Andreas, J.; Bockisch, A. and Beyer, J. (1995) Peripheral osteopenia in adult patients with insulin-dependent diabetes mellitus. Diabet. Med., 12, 874-879.
67. Schwartz, A. V.; Sellmeyer, D. E.; Ensrud, K. E.; Cauley, J. A.; Tabor, H. K.; Schreiner, P. J.; Jamal, S. A.; Black, D. M. and Cummings, S. R. (2001) Older women with diabetes have an increased risk of fracture: a prospective study. J. Clin. Endocrinol. Metab., 86, 1, 32-38.
68. Buysschaert, M.; Cauwe, F.; Jamart, J.; Brichant, C.; De Coster, P.; Magnan, A. and Donckier, J. (1992) Proximal femur density in type 1 and 2 diabetic patients. Diabetes Metab., 18, 32-37.
69. Tuominen, J. T.; Impivaara, O.; Puukka, P. and Ronnemaa, T. (1999) Bone mineral density in patients with type 1 and type 2 diabetes. Diabetes Care, 22, 1196-1200.
70. Singh, D. K.; Winocour, P.; Summerhayes, B.; Viljoen, A.; Sivakumar, G. and Farrington, K. (2010) Low serum osteoprotegerin levels in normoalbuminuric type 1 diabetes mellitus. Acta Diab., 47, 105-110.
71. Hie, M.; Shimono, M.; Fujii, K.; Tsukamoto, I. (2007) Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats. Bone, 41, 1045-1050.
72. Hie, M. and Tsukamoto, I. (2010) Increased expression of the receptor for activation of NF-kappaB and decreased runt-related transcription factor 2 expression in bone of rats with streptozotocininduced diabetes. Internat. J. Mol. Med., 26, 611-618.
73. McCabe, L. R. (2007) Understanding the pathology and mechanisms of type I diabetic bone loss. J. Cell. Biochem., 102, 1343-1357.
74. Verhaeghe, J.; van Herck, E.; Visser, W. J.; Suiker, A. M.; Thomasset, M.; Einhorn, T. A.; Faierman, E. and Bouillon, R. (1990) Bone and mineral metabolism in BB rats with long-term diabetes. Decreased bone turnover and osteoporosis. Diabetes, 39, 477-482.
75. Jang, Y. Y. and Sharkis, S. J. (2007) A low level of reactive oxygen species selects for primitive hematopoietic stem cells that may reside in the low-oxygenic niche. Blood, 110, 3056-3063.
76. Tothova, Z.; Kollipara, R.; Huntly, B. J.; Lee, B. H.; Castrillon, D. H.; Cullen, D. E.; McDowell, E. P.; Lazo-Kallanian, S.; Williams, I. R.; Sears, C.; Armstrong, S. A.; Passegue, E.; DePinho, R. A. and Gilliland, D. G. (2007) FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell, 128, 325-339.
77. Ito, K.; Hirao, A.; Arai, F.; Takubo, K.; Matsuoka, S.; Miyamoto, K.; Ohmura, M.; Naka, K.; Hosokawa, K.; Ikeda, Y. and Suda, T. (2006) Reactive oxygen species act through p38 MAPK to limit the lifespan of hematopoietic stem cells. Nat. Med., 12, 446-451.
78. Fadini, G. P.; Sartore, S.; Schiavon, M.; Albiero, M.; Baesso, I.; Cabrelle, A.; Agostini, C. and Avogaro, A. (2006) Diabetes impairs progenitor cell mobilisation after hindlimb ischaemia-reperfusion injury in rats. Diabetologia, 49, 3075-3084.
79. De Falco, E.; Avitabile, D.; Totta, P.; Straino, S.; Spallotta, F.; Cencioni, C.; Torella, A. R.; Rizzi, R.; Porcelli, D.; Zacheo, A.; Di Vito, L.; Pompilio, G.; Napolitano, M.; Melillo, G.; Capogrossi, M. C. and Pesce, M. (2009) Altered SDF-1-mediated differentiation of bone marrow-derived endothelial progenitor cells in diabetes mellitus. J. Cell. Mol. Med., 13, 3405-3414.
80. Aicher, A.; Heeschen, C.; Mildner-Rihm, C.; Urbich, C.; Ihling, C.; Technau-Ihling, K.; Zeiher, A. M. and Dimmeler, S. (2003) Essential role of endothelial nitric oxide synthase for mobilization of stem and progenitor cells. Nat. Med., 9, 1370-1376.
81. Gallagher, K. A.; Liu, Z. J.; Xiao, M.; Chen, H.; Goldstein, L. J.; Buerk, D. G.; Nedeau, A.; Thom, S. R. and Velazquez, O. C. (2007) Diabetic impairments in NO-mediated endothelial progenitor cell mobilization and homing are reversed by hyperoxia and SDF-1 alpha. J. Clin. Invest., 117, 1249-1259.
82. Thum, T.; Fraccarollo, D.; Schultheiss, M.; Froese, S.; Galuppo, P.; Widder, J. D.; Tsikas, D.; Ertl, G. and Bauersachs, J. (2007) Endothelial nitric oxide synthase uncoupling impairs endothelial progenitor cell mobilization and function in diabetes. Diabetes, 56, 666-674.
83. Kang, L.; Chen, Q.; Wang, L.; Gao, L.; Meng, K.; Chen, J.; Ferro, A. and Xu, B. (2009) Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes. Clin. Exp. Pharmacol. Physiol., 36, e47-e56.
84. Fiorina, P.; Pietramaggiori, G.; Scherer, S. S.; Jurewicz, M.; Mathews, J. C.; Vergani, A.; Thomas, G.; Orsenigo, E.; Staudacher, C.; La Rosa, S.; Capella, C.; Carothers, A.; Zerwes, H. G.; Luzi, L.; Abdi, R. and Orgill, D. P. (2010) The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing. Cell Transplant., 19, 1369-1381.
85. Busik, J. V.; Tikhonenko, M.; Bhatwadekar, A.; Opreanu, M.; Yakubova, N.; Caballero, S.; Player, D.; Nakagawa, T.; Afzal, A.; Kielczewski, J.; Sochacki, A.; Hasty, S.; Li Calzi, S.; Kim, S.; Duclas, S. K.; Segal, M. S.; Guberski, D. L.; Esselman, W. J.; Boulton, M. E. and Grant, M. B. (2009) Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J. Exp. Med., 206, 2897-2906.
86. Van Craenenbroeck, E. M.; Denollet, J.; Paelinck, B. P.; Beckers, P.; Possemiers, N.; Hoymans, V. Y.; Vrints, C. J. and Conraads, V. M. (2009) Circulating CD34+/KDR+ endothelial progenitor cells are reduced in chronic heart failure patients as a function of Type D personality. Clin. Sci. (Lond)., 117, 165-172.
87. Krankel, N.; Spinetti, G.; Amadesi, S. and Madeddu, P. (2011) Targeting stem cell niches and trafficking for cardiovascular therapy. Pharmacol. Ther., 129, 62-81.
88. Dimmeler, S.; Aicher, A.; Vasa, M.; Mildner-Rihm, C.; Adler, K.; Tiemann, M.; Rutten, H.; Fichtlscherer, S.; Martin, H. and Zeiher, A. M. (2001) HMG-CoA reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J. Clin. Invest., 108, 391-397.
89. Mangialardi, G.; Monopoli, A.; Ongini, E.; Spinetti, G.; Fortunato, O.; Emanueli, C. and Madeddu, P. (2011) Nitric oxide-donating statin improves multiple functions of circulating angiogenic cells. Br. J. Pharmacol., 164, 570-583.
90. Witkowski, S. and Hagberg, J. M. (2007) Progenitor cells and age: can we fight aging with exercise? J. Appl. Physiol., 102, 834-835.
91. Fadini, G. P.; Boscaro, E.; Albiero, M.; Menegazzo, L.; Frison, V.; de Kreutzenberg, S.; Agostini, C.; Tiengo, A. and Avogaro, A. (2010) The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha. Diabetes Care, 33, 1607-1609.
92. Spinetti, G.; Fortunato, O.; Cordella, D.; Portararo, P.; Krankel, N.; Katare, R.; Sala-Newby, G. B.; Richer, C.; Vincent, M. P.; Alhenc-Gelas, F.; Tonolo, G.; Cherchi, S.; Emanueli, C. and Madeddu, P. (2011) Tissue kallikrein is essential for invasive capacity of circulating proangiogenic cells. Circ. Res., 108, 284-293.